Novel oral Xa inhibitors in cardiology - Today and tomorrow

With an unrestricted educational grant from BRISTOL-MYERS SQUIBB and PFIZER ALLIANCE

Learning Objectives

  • To understand the latest data regarding novel oral Xa inhibitors
  • To learn about their use in different clinical situations
  • To understand future developments

Presentations available when logged in:

  • Introduction and objectives
  • Apixaban for stroke prevention in non-valvular atrial fibrillation: new insights
  • The atrial fibrillation patient with coronary artery disease
  • Anticoagulant strategies for elective cardioversion
  • Novel antithrombotic strategies in valvular diseases